Theoretical Considerations of Target-Mediated Drug Disposition Models: Simplifications and Approximations

Population Pharmacokinetics of Therapeutic Monoclonal Antibodies

(2010) Nathanael L. Dirks et al.   CLINICAL PHARMACOKINETICS

Population Modeling of Filgrastim PK-PD in Healthy Adults Following Intravenous and Subcutaneous Administrations

(2010) Wojciech Krzyzanski et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Dynamics of target-mediated drug disposition

(2009) Lambertus A. Peletier et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Target-mediated drug disposition model: approximations, identifiability of model parameters and applications to the population pharmacokinetic–pharmacodynamic modeling of biologics

(2009) Leonid Gibiansky et al.   Expert Opinion on Drug Metabolism & Toxicology

Numerical validation and properties of a rapid binding approximation of a target-mediated drug disposition pharmacokinetic model

(2009) Anshu Marathe et al.   JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS

Selection between Michaelis–Menten and target-mediated drug disposition pharmacokinetic models

(2009) Xiaoyu Yan et al.   JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS

Monoclonal Antibody Pharmacokinetics and Pharmacodynamics

(2008) W Wang et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Approximations of the target-mediated drug disposition model and identifiability of model parameters

(2008) Leonid Gibiansky et al.   JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS

Integrated Cellular Bone Homeostasis Model for Denosumab Pharmacodynamics in Multiple Myeloma Patients

(2008) A. Marathe et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS